Vimarsana
Biggest News Aggregation in the World

Page 2 - Early Drug Development Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Early Drug Development Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Early Drug Development Program Today - Breaking & Trending Today

Dr Desai on the Efficacy of Divarasib Plus Cetuximab in KRAS G12C–Mutant CRC - Vimarsana News

Dr Desai on the Efficacy of Divarasib Plus Cetuximab in KRAS G12C–Mutant CRC

Jayesh Desai, MBBS, FRACP, discusses efficacy data for the combination of divarasib plus cetuximab in patients with colorectal cancer harboring a KRAS G12C mutation from a phase 1B study.